Norgestrel

Research use only, not for human use.

Norgestrel is a synthetic progestin commonly used alone or in combination with an estrogen for contraception.

Norgestrel is a synthetic progestin commonly used alone or in combination with an estrogen for contraception. Norgestrel suppresses the secretion of luteinizing and follicle-stimulating hormones (LH and FSH), thickens cervical mucus, and slows the transit of ova through the fallopian tubes.(In Vitro):Norgestrel (20 μM; 24 hours; 661W cells) treatment significantly increases cellular viability after serum deprivation and so it is demonstrated that Norgestrel is neuroprotective to stressed 661W cells.Norgestrel (20 μM; 24 hours; 661W cells) treatment decreases apoptotic induced cleavage of PARP and caspase-3.Norgestrel (20 μM; 6 hours; 661W cells) treatment bFGF is results in a significant upregulation of bFGF mRNA in photoreceptor cells.(In Vivo):Norgestrel (100 mg/kg; intraperitoneal injection; for 6, 24 or 48 hours; Balb/c mice) treatment can prevent light-induced ROS in photoreceptor cells, and subsequent cell death. Norgestrel acts via post-translational modulation of the major antioxidant transcription factor Nrf2; bringing about its phosphorylation, subsequent nuclear translocation, and increases levels of its effector protein superoxide dismutase 2 (SOD2).

——

——

Ovrette

Endocrinology/Hormones

Estrogen Receptor/ERR

ER

——

——

6533-00-2

312.45

C21H28O2

>98% (HPLC)

DMSO: 10 mM

O=C1CC[C@]2([H])[C@@]3([H])CC[C@]4(CC)[C@](O)(C#C)CC[C@@]4([H])[C@]3([H])CCC2=C1

dl-13-beta-Ethyl-17-alpha-ethynyl-17-beta-hydroxygon-4-en-3-one

(-20℃)

With Ice Pack

≥ 2 years